Korean Circulation Journal

The Korean Society of Cardiology (대한심장학회)
권호 표지
DOI QR코드

DOI QR Code

Electrical Remodeling of Left Atrium Is a Better Predictor for Recurrence Than Structural Remodeling in Atrial Fibrillation Patients Undergoing Radiofrequency Catheter Ablation

  • Yun Gi Kim (Arrhythmia Center, Korea University Medicine Anam Hospital) ;
  • Ha Young Choi (Arrhythmia Center, Korea University Medicine Anam Hospital) ;
  • Jaemin Shim (Arrhythmia Center, Korea University Medicine Anam Hospital) ;
  • Kyongjin Min (Arrhythmia Center, Korea University Medicine Anam Hospital) ;
  • Yun Young Choi (Arrhythmia Center, Korea University Medicine Anam Hospital) ;
  • Jong-Il Choi (Arrhythmia Center, Korea University Medicine Anam Hospital) ;
  • Young-Hoon Kim (Arrhythmia Center, Korea University Medicine Anam Hospital)
  • Received : 2021.09.24
  • Accepted : 2021.12.01
  • Published : 2022.05.01
Download PDF
⟨ Previous Next ⟩

Abstract

Background and Objectives: Recurrence rates after radiofrequency catheter ablation (RFCA) in atrial fibrillation (AF) patients are not low especially in non-paroxysmal AF. The diameter of left atrium (LA) has been widely used to predict the recurrence after RFCA for decades. However, LA diameter represents structural remodeling of LA and does not reflect electrical remodeling. We aimed to determine the predictive value of electrical remodeling of LA which is represented by the amount of low voltage zone (LVZ). Methods: We performed a retrospective cohort analysis of AF patients who underwent de novo RFCA in a single-center. Results: A total of 3,120 AF patients with de novo RFCA were analyzed. Among these patients, 537 patients underwent an electroanatomic mapping with bipolar voltage measurement of LA. The diameter of LA and flow velocity of LA appendage (LAA) differed significantly according to quartile group of LVZ area and percentage: patients with high LVZ had large LA diameter and low LAA flow velocity (p<0.001). Freedom from late recurrence (LR) was significantly lower in patients with high LVZ area and percentage (p<0.001). The diameter and surface area of LA had area under curve (AUC) of 0.592 and 0.593, respectively (p=0.002 for both). The predictive value of LVZ area (AUC, 0.676) and percentage (AUC, 0.671) were both superior compared with LA diameter (p=0.011 and 0.027 for each comparison). Conclusions: In conclusion, LVZ can predict freedom from LR after RFCA in AF patients. Predictive value was higher in parameters reflecting electrical rather than structural remodeling of LA.

Keywords

Acknowledgement

This work was supported by the National Research Foundation of Korea (NRF) grant funded by the Korea government (Ministry of Science and ICT; R2101281).

References

  1. Go AS, Hylek EM, Phillips KA, et al. Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study. JAMA 2001;285:2370-5. https://doi.org/10.1001/jama.285.18.2370
  2. Miyasaka Y, Barnes ME, Gersh BJ, et al. Secular trends in incidence of atrial fibrillation in Olmsted County, Minnesota, 1980 to 2000, and implications on the projections for future prevalence. Circulation 2006;114:119-25. https://doi.org/10.1161/CIRCULATIONAHA.105.595140
  3. Corley SD, Epstein AE, DiMarco JP, et al. Relationships between sinus rhythm, treatment, and survival in the Atrial Fibrillation Follow-Up Investigation of Rhythm Management (AFFIRM) Study. Circulation 2004;109:1509-13. https://doi.org/10.1161/01.CIR.0000121736.16643.11
  4. Wyse DG, Waldo AL, DiMarco JP, et al. A comparison of rate control and rhythm control in patients with atrial fibrillation. N Engl J Med 2002;347:1825-33. https://doi.org/10.1056/NEJMoa021328
  5. Wilber DJ, Pappone C, Neuzil P, et al. Comparison of antiarrhythmic drug therapy and radiofrequency catheter ablation in patients with paroxysmal atrial fibrillation: a randomized controlled trial. JAMA 2010;303:333-40. https://doi.org/10.1001/jama.2009.2029
  6. Packer DL, Mark DB, Robb RA, et al. Effect of catheter ablation vs antiarrhythmic drug therapy on mortality, stroke, bleeding, and cardiac arrest among patients with atrial fibrillation: the cabana randomized clinical trial. JAMA 2019;321:1261-74. https://doi.org/10.1001/jama.2019.0693
  7. Pappone C, Augello G, Sala S, et al. A randomized trial of circumferential pulmonary vein ablation versus antiarrhythmic drug therapy in paroxysmal atrial fibrillation: the APAF Study. J Am Coll Cardiol 2006;48:2340-7. https://doi.org/10.1016/j.jacc.2006.08.037
  8. Marrouche NF, Brachmann J, Andresen D, et al. Catheter ablation for atrial fibrillation with heart failure. N Engl J Med 2018;378:417-27. https://doi.org/10.1056/NEJMoa1707855
  9. Verma A, Jiang CY, Betts TR, et al. Approaches to catheter ablation for persistent atrial fibrillation. N Engl J Med 2015;372:1812-22. https://doi.org/10.1056/NEJMoa1408288
  10. Kim YG, Choi JI, Boo KY, et al. Clinical and echocardiographic risk factors predict late recurrence after radiofrequency catheter ablation of atrial fibrillation. Sci Rep 2019;9:6890.
  11. Yamaguchi T, Tsuchiya T, Fukui A, et al. Impact of the extent of low-voltage zone on outcomes after voltage-based catheter ablation for persistent atrial fibrillation. J Cardiol 2018;72:427-33. https://doi.org/10.1016/j.jjcc.2018.04.010
  12. Rolf S, Kircher S, Arya A, et al. Tailored atrial substrate modification based on low-voltage areas in catheter ablation of atrial fibrillation. Circ Arrhythm Electrophysiol 2014;7:825-33. https://doi.org/10.1161/CIRCEP.113.001251
  13. Marrouche NF, Wilber D, Hindricks G, et al. Association of atrial tissue fibrosis identified by delayed enhancement MRI and atrial fibrillation catheter ablation: the DECAAF study. JAMA 2014;311:498-506. https://doi.org/10.1001/jama.2014.3
  14. Kircher S, Arya A, Altmann D, et al. Individually tailored vs. standardized substrate modification during radiofrequency catheter ablation for atrial fibrillation: a randomized study. Europace 2018;20:1766-75.  https://doi.org/10.1093/europace/eux310
  15. Verma A, Wazni OM, Marrouche NF, et al. Pre-existent left atrial scarring in patients undergoing pulmonary vein antrum isolation: an independent predictor of procedural failure. J Am Coll Cardiol 2005;45:285-92. https://doi.org/10.1016/j.jacc.2004.10.035
  16. Kim YG, Shim J, Kim DH, et al. Characteristics of atrial fibrillation patients suffering atrioesophageal fistula after radiofrequency catheter ablation. J Cardiovasc Electrophysiol 2018;29:1343-51. https://doi.org/10.1111/jce.13671
  17. Kim YG, Han S, Choi JI, et al. Impact of persistent left superior vena cava on radiofrequency catheter ablation in patients with atrial fibrillation. Europace 2019;21:1824-32. https://doi.org/10.1093/europace/euz254
  18. Kim YG, Han KD, Choi JI, et al. Non-genetic risk factors for atrial fibrillation are equally important in both young and old age: a nationwide population-based study. Eur J Prev Cardiol 2021;28:666-76. https://doi.org/10.1177/2047487320915664
  19. Hanley JA, McNeil BJ. A method of comparing the areas under receiver operating characteristic curves derived from the same cases. Radiology 1983;148:839-43. https://doi.org/10.1148/radiology.148.3.6878708
  20. Kim YG, Shim J, Oh SK, Lee KN, Choi JI, Kim YH. Risk factors for ischemic stroke in atrial fibrillation patients undergoing radiofrequency catheter ablation. Sci Rep 2019;9:7051.
  21. Lee KN, Roh SY, Baek YS, et al. Long-term clinical comparison of procedural end points after pulmonary vein isolation in paroxysmal atrial fibrillation: Elimination of nonpulmonary vein triggers versus noninducibility. Circ Arrhythm Electrophysiol 2018;11:e005019.
  22. Haldar S, Khan HR, Boyalla V, et al. Catheter ablation vs. thoracoscopic surgical ablation in long-standing persistent atrial fibrillation: CASA-AF randomized controlled trial. Eur Heart J 2020;41:4471-80. https://doi.org/10.1093/eurheartj/ehaa658
  23. Corradi D, Callegari S, Maestri R, Benussi S, Alfieri O. Structural remodeling in atrial fibrillation. Nat Clin Pract Cardiovasc Med 2008;5:782-96. https://doi.org/10.1038/ncpcardio1370
  24. Corradi D. Atrial fibrillation from the pathologist's perspective. Cardiovasc Pathol 2014;23:71-84. https://doi.org/10.1016/j.carpath.2013.12.001
  25. Allessie MA, de Groot NM, Houben RP, et al. Electropathological substrate of long-standing persistent atrial fibrillation in patients with structural heart disease: longitudinal dissociation. Circ Arrhythm Electrophysiol 2010;3:606-15. https://doi.org/10.1161/CIRCEP.109.910125
  26. Myerburg RJ, Nilsson K, Befeler B, Castellanos A Jr, Gelband H. Transverse spread and longitudinal dissociation in the distal A-V conducting system. J Clin Invest 1973;52:885-95. https://doi.org/10.1172/JCI107253
  27. Masuda M, Fujita M, Iida O, et al. Influence of underlying substrate on atrial tachyarrhythmias after pulmonary vein isolation. Heart Rhythm 2016;13:870-8. https://doi.org/10.1016/j.hrthm.2015.12.029
  28. Matsuda Y, Masuda M, Asai M, et al. A new clinical risk score for predicting the prevalence of low-voltage areas in patients undergoing atrial fibrillation ablation. J Cardiovasc Electrophysiol 2020;31:3150-8. https://doi.org/10.1111/jce.14761
  29. Sanders P, Morton JB, Davidson NC, et al. Electrical remodeling of the atria in congestive heart failure: electrophysiological and electroanatomic mapping in humans. Circulation 2003;108:1461-8. https://doi.org/10.1161/01.CIR.0000090688.49283.67
  30. Yang B, Jiang C, Lin Y, et al. STABLE-SR (electrophysiological substrate ablation in the left atrium during sinus rhythm) for the treatment of nonparoxysmal atrial fibrillation: a prospective, multicenter randomized clinical trial. Circ Arrhythm Electrophysiol 2017;10:e005405.